.5 semaglutide weight loss $99.00 | --- 5 mg / 2 ml --- 2 ml vial --- Glucagon-Like Peptide-1 (GLP-1) Mind-blowing' weight loss with semaglutide

September 5th, 2025: Research Suggests GLP-1 Medications May Raise Kidney Cancer Risk Amid Growing Litigation A new study published in JAMA Oncology suggests that GLP-1 receptor agonists such as Ozempic and Mounjaro could increase the risk of kidney cancer, despite appearing to lower the risk of certain other cancers

Human stem cell modeling in neurofibromatosis type 1 (NF1)

Luo ZY, Li X, Chen CT, et al

Safety and toxicity of nanomaterials in ophthalmology diseases In recent years, the employment of nanomaterials has emerged as a promising strategy for addressing and diagnosing a wide array of ophthalmic disorders

Now, researchers are asking a bigger question: could these medications also influence breast cancer risk, treatment tolerance, or long-term outcomes